Dentsply Sirona Inc (XRAY)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$17.69

Buy

$17.70

arrow-up$0.12 (+0.68%)

Prices updated at 12 Nov 2024, 22:50 EST
| Prices minimum 15 mins delay
|
Prices in USD

Dentsply Sirona Inc is a designer, developer, manufacturer and marketer of consumable dental products for the professional dental market. It also manufactures and markets other consumable medical device products.

Income statement

20222023
3,922m3,965m
2,127m2,086m
357m282m
9.107.11
-950m-132m
-662m249m
Sales, General and administrative1,596m1,620m
Interest expenses65m81m
Provision for income taxes-105m-43m
Operating expenses1,770m1,804m
Income before taxes-1,055m-175m
Net income available to common shareholders-950m-132m
-4.41-0.62
Net interest income-65m-81m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-4.41-0.62
Free cash flow per share2.02891.0219
Book value/share16.781216.2886
Debt equity ratio0.5182370.583359

Balance sheet

20222023
Current assets1,893m1,973m
Current liabilities1,170m1,425m
Total capital5,637m5,089m
Total debt2,147m2,299m
Total equity3,811m3,293m
Total non current liabilities--
Loans1,826m1,796m
Total assets7,643m7,370m
Total liabilities--
Cash and cash equivalents365m334m
Common stock215m207m

Cash flow

20222023
Cash at beginning of period339m365m
Cash dividends paid--116m
368m228m
Investments (gains) losses-138m-89m
365m334m
Net income--
517m377m
-149m-149m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.